View this email in your browser

UBC-led research team receives over $40 million for Advanced Therapeutics Manufacturing Facility 

The Advanced Therapeutics Manufacturing Facility (ATMF) on UBC’s Vancouver campus will be a cornerstone of Canada’s life sciences ecosystem, enabling researchers and biotech start-ups to turn their discoveries into patient-ready treatments for Canadians. 

Link to full story

MS Research Network timeline

As this is our inaugural newsletter, we invite you to learn more about the MS Research Network. Take a look at our timeline of milestones so far. 

Funding opportunities

All opportunities
 

Events

All events
 

Innovator spotlight

Dr. Harold Atkins is a senior clinician investigator of the Cancer Therapeutics Program with Ottawa Hospital Research Institute, physician with the Transplant and Cell Therapy Program at the Ottawa Hospital. He pioneered the use of hematopoietic stem cell transplantation (HSCT) for immune system repair in autoimmune diseases such as multiple sclerosis, myasthenia gravis, and stiff person syndrome...

Read full story

Careers

Feedback

We invite you to complete a brief survey to share your thoughts as members of our growing community. Your feedback will be invaluable in shaping the readership experience and future content of the The Signal.

Survey link


FAST FACTS

UBC Faculty of Medicine
317 - 2194 Health Sciences Mall
Vancouver, BC Canada V6T 1Z3



mednet.med.ubc.ca

 

 

 

The MS Research Network is a is a new publication, led by the Office of Research within UBC's Faculty of Medicine and created for the MS community within BC and beyond.

View this email in your browser

© Copyright The University of British Columbia
Unsubscribe